Abstract
BackgroundThe present study investigates the effects and mechanisms of α-Lipoic acid (LA) on myocardial infarct size, cardiac function and cardiomyocyte apoptosis in rat hearts subjected to in vivo myocardial ischemia/reperfusion (MI/R) injury.Methodology/Principal FindingsMale adult rats underwent 30 minutes of ischemia followed by 3, 24, or 72 h of reperfusion. Animals were pretreated with LA or vehicle before coronary artery ligation. The level of MI/R- induced LDH and CK release, infarct size, cardiomyocyte apoptosis and cardiac functional impairment were examined and compared. Western blot analysis was performed to elucidate the mechanism of LA pretreatment. The level of inflammatory cytokine TNF-α released to serum and accumulated in injured myocardium as well as neutrophil accumulation in injured myocardium were also examined after MI/R injury. Our results reveal that LA administration significantly reduced LDH and CK release, attenuated myocardial infarct size, decreased cardiomyocytes apoptosis, and partially preserved heart function. Western blot analysis showed that LA pretreatment up-regulated Akt phosphorylation and Nrf2 nuclear translocation while producing no impact on p38MAPK activation or nitric oxide (NO) production. LA pretreatment also increased expression of HO-1, a major target of Nrf2. LA treatment inhibited neutrophil accumulation and release of TNF-α. Moreover, PI3K inhibition abolished the beneficial effects of LA.Conclusions/SignificanceThis study indicates that LA attenuates cardiac dysfunction by reducing cardiomyoctyes necrosis, apoptosis and inflammation after MI/R. LA exerts its action by activating the PI3K/Akt pathway as well as subsequent Nrf2 nuclear translocation and induction of cytoprotective genes such as HO-1.
Highlights
Restoring coronary blood flow using pharmacological or mechanical interventions following acute myocardial ischemia is essential for the salvation of viable myocardium
Lipoic acid (LA) Reduces CK and LDH Release After I/R Injury LA significantly decreased the serum levels of the necrotic cell death markers, lactate dehydrogenase (LDH) and creatinine kinase (CK), compared with the I/R+V group (CK: 114.9611.07 vs 163.167.648 U/g protein, P = 0.005; LDH: 113.369.775 vs 170.267.087 U/L, P = 0.0015). This effect was largely alleviated by the PI3K inhibitor wortmannin (CK: 151.669.623 vs 114.9611.07 U/g protein, P = 0.031; LDH: 151.569.962 vs 113.369.775 U/L, P = 0.026) (Figure 1a,b)
In the present study, using an in vivo rat model of myocardial ischemia/reperfusion (MI/R), we evaluated the protective effect of LA against MI/R and explored the mechanisms involved
Summary
Restoring coronary blood flow (reperfusion) using pharmacological or mechanical interventions following acute myocardial ischemia is essential for the salvation of viable myocardium. A number of strategies and pharmacological agents are shown to ameliorate reperfusion injury in these animal models. Translation of these strategies and agents to the clinical setting has been disappointing [3]. To improve clinical outcomes in acute myocardial infarction, it is of pivotal importance to develop new pharmacological agents for limiting reperfusion injury and preserving heart function. The present study investigates the effects and mechanisms of a-Lipoic acid (LA) on myocardial infarct size, cardiac function and cardiomyocyte apoptosis in rat hearts subjected to in vivo myocardial ischemia/reperfusion (MI/R) injury
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have